A novel overlap syndrome: Systemic sclerosis associated with antiphospholipid syndrome - A case series

Annals of the New York Academy of Sciences

Volumn 1108, Issue , 2007, Pages 497-504

  Zandman Goddard, Gisele ^a,b   Tweezer Zaks, Nurit ^b,c   Shalev, Tamar ^b,c   Levy, Yair ^b,d   Ehrenfeld, Michael ^b,c   Langevitz, Pnina ^b,c  

^a WOLFSON MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d MEIR MEDICAL CENTER   (Israel)

Author keywords

Anti cardiolipin antibodies; Antiphospholipid syndrome; Overlap syndrome; Systemic sclerosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CIPROFLOXACIN; CLINDAMYCIN; COLCHICINE; ENOXAPARIN; ILOPROST; IMMUNOGLOBULIN G; METHOTREXATE; OMEPRAZOLE; OXYCODONE; PENICILLAMINE; PREDNISONE; PROSTACYCLIN; PROSTACYCLIN DERIVATIVE; SILDENAFIL; STEROID; UNIPROST; WARFARIN;

ADD ON THERAPY; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIPHOSPHOLIPID SYNDROME; CASE REPORT; CONFERENCE PAPER; DEATH; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG DOSE INCREASE; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; ESOPHAGEAL DYSMOTILITY; ESOPHAGUS DISEASE; FEMALE; HEART PALPITATION; HOSPITAL PATIENT; HUMAN; ISRAEL; MEDICAL RECORD REVIEW; MEDLINE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; PLASTIC SURGERY; POLYARTHRITIS; PYODERMA GANGRENOSUM; RAYNAUD PHENOMENON; SKIN ULCER; SYNDROME CREST; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UNSPECIFIED SIDE EFFECT;

EID: 34948839898     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1422.053     Document Type: Conference Paper

References (11)

1. ASHERSON, R.A., R. CERVERA, J.C. PIETTE, et al. 1996. The antiphospholipid syndrome: history, definition, classification and differential diagnosis. In The Antiphospholipid Syndrome. R.A. Asherson, R. Cervera, J.C. Piette, Y. Shoenfeld, Eds.: 3-12. CRS Press. Boca Raton, USA.
2. ASHERSON, R.A. & R. CERVERA. 1994. Primary, secondary and other variants of the antiphospholipid syndrome. Lupus 3: 293-298.
3. SHERER, Y., A. LIVNEH, Y. LEVY, et al. 2000. Dermatomyositis and polymyositis associated with the antiphospholipid syndrome - a novel overlap syndrome. Lupus 9: 42-46.
4. SANNA, G., M.L. BERTOLACCINI, A. MAMELI, et al. 2005. Antiphospholipid Ab in patients with scleroderma: prevalence and clinical significance. Ann. Rheum. Dis. 64: 1795-1796.
5. MERKEL, P.A., Y. CHANG, S.S. PIERANGELI, et al. 1996. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am. J. Med. 101: 576-583.
6. MINATANI, M., J. TAKASAKI, H. IWATA, et al. 2000. Acute interstitial pneumonia associated with antiphospholipid syndrome in a patient with systemic sclerosis. Clin. Exp. Rheumatol. 18: 786.
7. CHUN, W.H., D. BANG & S.K. LEE. 1996. Antiphospholipid syndrome associated with progressive systemic sclerosis. J. Dermatol. 23: 347-351.
8. WHITTAKER, R., A. BARNETT & P. RYAN. 1993. Antiphospholipid syndrome in scleroderma. J. Rheumatol. 20: 1598-1600.
9. KANE, D., F. MCSWEENEY, N. SWAN, et al. 1998. Catastrophic antiphospholipid antibody syndrome in primary systemic sclerosis. J. Rheumatol. 25: 810-812.
10. MATSUURA, E., K. KOBAYASHI, K. INOUE, et al. 2005. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis. Lupus 14: 736-741.
11. LOPEZ, L.R., D.F. SIMPSON, B.L. HURLEY, et al. 2005. OxLDL/beta}2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement. Ann. N. Y. Acad. Sci. 1051: 13-22.